Abstract:Sir: Akimoto and coauthors recently published a study of vascular endothelial growth factor (VEGF) and flap survival in a rat model.1 Using a paired dorsal flap preparation, these investigators reported enhanced flap survival when VEGF combined with a Clostridium-derived collagen binding domain (CB-VEGF) was injected into flaps at the time of elevation. This improvement in flap survival was established relative to flaps injected with saline and unmodified VEGF, neither of which resulted in enhanced flap survival in these experiments. We wish to point out two problems with this study. First, Akimoto et al. ignored a large body of previous work studying the effects of VEGF on flap survival (Table 1).2 At least 11 studies have documented increased survival of dorsal rat flaps with various routes of VEGF application, and none of these studies is mentioned in their article. At least 41 articles have been published examining the effects of VEGF in other rat flap models. Only four of these articles are cited by Akimoto et al., and these citations include only gene therapy experiments. The larger numbers of studies using locally injected VEGF are not noted. By ignoring this large body of work, the authors are giving their observations of CB-VEGF effects an unwarranted semblance of novelty.Table 1: Rat Models Demonstrating Enhanced Flap Survival with VEGF Administration*Second, neglect of previously published work deprived the authors of an opportunity to address an important problem with their own experimental findings. In this study, injection of unmodified VEGF had no positive effect on flap survival. This result is in direct contradiction to the many studies noted above in which VEGF has repeatedly been demonstrated to enhance survival in dorsal rat flap models. This disagreement with a large body of previously published work permits speculation that the CB-VEGF effect described in this experiment is simply the VEGF effect noted by many other investigators. The lack of effect in the authors’ VEGF group could reflect a problem in the preparation, maintenance, or administration of their VEGF. The authors discuss the well-known concept of the short half-life of VEGF and postulate that there is a “sustained-release” effect created by CB-VEGF. They offer no evidence for this effect beyond the improved flap survival relative to VEGF in their own experiment. Given the context of previous work by other investigators, a simple explanation could conclude that their CB-VEGF demonstrated the well-described improvement of flap tissue survival noted in many models and their finding of no tissue survival improvement with simple VEGF was an anomaly. Their contention that their CB-VEGF findings represent an exceptional characteristic of this compound appears unwarranted. Given the short half-life of VEGF, it is reasonable to investigate the possibilities of this growth factor acting through cascades of biologic activity.3 This conceptual framework suggests that future work could most productively be applied to understanding the interrelationships of VEGF rather than modifying the agent itself. DISCLOSURE The authors have no financial interest to declare in relation to the content of this article. William C. Lineaweaver, M.D. JMS Burn and Reconstruction Center, Jackson, Miss. Feng Zhang, M.D., Ph.D. Division of Plastic Surgery, University of Mississippi Medical Center, Jackson, Miss.

[Comparison of the Effect of Local Administration of Endothelial Progenitor Cells and VEGF on Improving Neovascularization in Flap Prefabrication].

Enhancement of Viability of Fat Grafts in Nude Mice by Endothelial Progenitor Cells

Vascular endothelial growth factor on function of endothelial progenitor cells from peripheral blood

Effect of Calcium Alginate Microsphere Loaded with Vascular Endothelial Growth Factor on Adipose Tissue Transplantation.

Effect of chitosan nanospheres loaded with VEGF on adipose tissue transplantation: a preliminary report.

Combination of Stromal-Derived Factor-1Α and Vascular Endothelial Growth Factor Gene-Modified Endothelial Progenitor Cells is More Effective for Ischemic Neovascularization

ACCELERATED MATURATION OF EXPANDED PREFABRICATED FLAPS BY USE OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND BASIC FIBROBLAST GROWTH FACTOR IN RABBITS

Highly Efficient Local Delivery of Endothelial Progenitor Cells Significantly Potentiates Angiogenesis and Full-Thickness Wound Healing.

Experiment of the Alteration of Vascular and Endogenous Vascular Endothelial Growth Factor in the Survival Process of the Reverse-Flow Axial Skin Flap

SURVIVAL OF RAT OVER-AREA ABDOMINAL AXIAL SKIN FLAP AFTER APPLICATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR GENE AND SURGICAL DELAY

[Effect of adipose-derived stem cell derived exosomes on angiogenesis after skin flap transplantation in rats]

Accelerating Flap Maturation by Vascular Endothelium Growth Factor in a Rat Tube Flap Model

Comparison of Revascularization of Bone Marrow Mononuclear Cells and Endothelial Progenitor Cells Transplantation

Transplantation of VEGF165-gene-transfected Endothelial Progenitor Cells in the Treatment of Chronic Venous Thrombosis in Rats.

[Study on Effect of PluronicF-127 and Vascular Endothelial Growth Factor Composite Delivery System for Improving the Survival of Grafted Fat].

The Effects of Local Injection of Exosomes Derived from BMSCs on Random Skin Flap in Rats.

Efficacy of Combined in-vivo Electroporation-Mediated Gene Transfer of VEGF, HGF, and IL-10 on Skin Flap Survival, Monitored by Label-Free Optical Imaging: A Feasibility Study

Mesenchymal Stem Cells Transduced by Vascular Endothelial Growth Factor Gene for Ischemic Random Skin Flaps

Effects of CB-VEGF-A Injection in Rat Flap Models for Improved Survival

Fibrin Promotes Survival and Differentiation of Endothelial Progenitor Cells after Transplantation

Effects of Bone Marrow-Derived Endothelial Progenitor Cell Transplantation on Vein Microenvironment in a Rat Model of Chronic Thrombosis.